293 related articles for article (PubMed ID: 18938074)
41. X-ray computed tomography contrast agents prepared by seeded growth of gold nanoparticles in PEGylated dendrimer.
Kojima C; Umeda Y; Ogawa M; Harada A; Magata Y; Kono K
Nanotechnology; 2010 Jun; 21(24):245104. PubMed ID: 20498528
[TBL] [Abstract][Full Text] [Related]
42. [Synthesis, characterization and relaxivity of dimeric DTPA-gadonium (III) complexes with long chain alkyl esters of L-lysine].
Yu KC; Liu LY; Wan FX; Zhou JL; Ding SW; Ye CH
Guang Pu Xue Yu Guang Pu Fen Xi; 2006 Apr; 26(4):670-3. PubMed ID: 16836136
[TBL] [Abstract][Full Text] [Related]
43. Pulse repetition time and contrast enhancement: simulation study of Gd-BOPTA and conventional contrast agent at different field strengths.
Yrjänä SK; Vaara T; Karttunen A; Koivukangas J
Invest Radiol; 2008 Apr; 43(4):267-75. PubMed ID: 18340251
[TBL] [Abstract][Full Text] [Related]
44. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent.
Bolskar RD; Benedetto AF; Husebo LO; Price RE; Jackson EF; Wallace S; Wilson LJ; Alford JM
J Am Chem Soc; 2003 May; 125(18):5471-8. PubMed ID: 12720461
[TBL] [Abstract][Full Text] [Related]
45. Lanthanides in magnetic resonance imaging.
Bottrill M; Kwok L; Long NJ
Chem Soc Rev; 2006 Jun; 35(6):557-71. PubMed ID: 16729149
[TBL] [Abstract][Full Text] [Related]
46. Probing the interaction of the biotin-avidin complex with the relaxivity of biotinylated Gd-DTPA.
Langereis S; Kooistra HA; van Genderen MH; Meijer EW
Org Biomol Chem; 2004 May; 2(9):1271-3. PubMed ID: 15105914
[TBL] [Abstract][Full Text] [Related]
47. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA.
Tamada T; Ito K; Sone T; Yamamoto A; Yoshida K; Kakuba K; Tanimoto D; Higashi H; Yamashita T
J Magn Reson Imaging; 2009 Mar; 29(3):636-40. PubMed ID: 19243060
[TBL] [Abstract][Full Text] [Related]
48. Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI.
Accardo A; Tesauro D; Roscigno P; Gianolio E; Paduano L; D'Errico G; Pedone C; Morelli G
J Am Chem Soc; 2004 Mar; 126(10):3097-107. PubMed ID: 15012139
[TBL] [Abstract][Full Text] [Related]
49. MR molecular imaging of thrombus: development and application of a Gd-based novel contrast agent targeting to P-selectin.
Wang XF; Jin PP; Tong Zhou ; Zhao YP; Ding QL; Wang DB; Zhao GM; Jing-Dai ; Wang HL; Ge HL
Clin Appl Thromb Hemost; 2010 Apr; 16(2):177-83. PubMed ID: 19141485
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and physicochemical characterization of Gd-C4-thyroxin-DTPA, a potential MRI contrast agent. Evaluation of its affinity for human serum albumin by proton relaxometry, NMR diffusometry, and electrospray mass spectrometry.
Henoumont C; Vander Elst L; Laurent S; Muller RN
J Phys Chem B; 2010 Mar; 114(10):3689-97. PubMed ID: 20175550
[TBL] [Abstract][Full Text] [Related]
51. [Preparation of a novel targeted MR contrast agent Gd-DTPA-streptavidin and exploration of its reaction conditions].
Liu X; Xu YK; Huang QL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):15-7. PubMed ID: 14724085
[TBL] [Abstract][Full Text] [Related]
52. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
[TBL] [Abstract][Full Text] [Related]
53. Gold nanoparticles conjugated with epidermal growth factor and gadolinium for precision delivery of contrast agents in magnetic resonance imaging.
Queiroz SM; Veriato TS; Raniero L; Castilho ML
Radiol Phys Technol; 2024 Mar; 17(1):153-164. PubMed ID: 37991701
[TBL] [Abstract][Full Text] [Related]
54. Synthesis neutral rare earth complexes of diethylenetriamine-N,N''-bis(acetyl-isoniazid)-N,N',N''-triacetic acid as potential contrast enhancement agents for magnetic resonance imaging.
Zhang DW; Yang ZY; Wang BD; Zhang SP; Yang RD
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1203-6. PubMed ID: 16880671
[TBL] [Abstract][Full Text] [Related]
55. Improved molecular imaging contrast agent for detection of human thrombus.
Winter PM; Caruthers SD; Yu X; Song SK; Chen J; Miller B; Bulte JW; Robertson JD; Gaffney PJ; Wickline SA; Lanza GM
Magn Reson Med; 2003 Aug; 50(2):411-6. PubMed ID: 12876719
[TBL] [Abstract][Full Text] [Related]
56. Contrast agents: magnetic resonance.
Burtea C; Laurent S; Vander Elst L; Muller RN
Handb Exp Pharmacol; 2008; (185 Pt 1):135-65. PubMed ID: 18626802
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of proton relaxation for enzyme-manipulated, multicomponent gold-magnetic nanoparticle chains.
Jaganathan H; Gieseck RL; Hudson K; Kellogg M; Ramaswamy AK; Raver KE; Smith T; Vacchiano AN; Wager A; Ivanisevic A
Chemphyschem; 2010 Dec; 11(17):3664-72. PubMed ID: 21077085
[TBL] [Abstract][Full Text] [Related]
58. Tuning the magnetic resonance imaging properties of positive contrast agent nanoparticles by surface modification with RAFT polymers.
Rowe MD; Chang CC; Thamm DH; Kraft SL; Harmon JF; Vogt AP; Sumerlin BS; Boyes SG
Langmuir; 2009 Aug; 25(16):9487-99. PubMed ID: 19422256
[TBL] [Abstract][Full Text] [Related]
59. Magnetic resonance coronary angiography: comparison between a Gd-BOPTA- and a Gd-DTPA-enhanced spoiled gradient-echo sequence and a non-contrast-enhanced steady-state free-precession sequence.
Nassenstein K; Breuckmann F; Hunold P; Barkhausen J; Schlosser T
Acta Radiol; 2009 May; 50(4):406-11. PubMed ID: 19308763
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
